Chelsea
Corey

Representing Petersen Energia Inversora, S.A.U. and Petersen Energia, S.A.U. in a SDNY action against the Argentine Republic and YPF, S.A., alleging claims for breach of contract and promissory estoppel arising from defendants’ failure to comply with their tender offer requirements.

Representing Global Brokerage, Inc. and its CEO and CFO in a federal securities class action filed in SDNY alleging claims under Sections 10(b) and 20(a) of the Securities and Exchange Act of 1934.

Represented Forex Capital Markets LLC in consumer class actions in SDNY alleging claims of breach of contract, breach of fiduciary duty, negligence and consumer fraud.

Represented Citigroup Global Markets Inc. and Citigroup Global Markets Limited in an adversary proceeding filed in the Thornburg Mortgage bankruptcy cases in Maryland seeking to avoid over $2 billion in transfers and other obligations that Thornburg made or assumed prior to bankruptcy. Obtained dismissal of the federal and state constructive fraudulent transfer claims asserted by the Trustee.

Represented a Big Four accounting firm in what was reported at the time to be the highest-stakes accounting malpractice case in U.S. history to go to trial. The plaintiff, the trustee of a bankrupt mortgage originator, sought $5.5 billion in damages in Florida state court. The case settled mid-trial.

Represented Darwin Deason, Xerox’s third-largest shareholder, in a New York State action to stop a change of control transaction between Fuji and Xerox and for damages against Fuji for aiding and abetting breaches of fiduciary duty by the Xerox board. Obtained a preliminary injunction of the transaction after a two-day evidentiary hearing and defeated motions to dismiss by Xerox board and Fuji.

Represented FXCM LLC in a regulatory proceeding filed by the CFTC in SDNY.

Represented The Renco Group and other affiliated entities in an action filed by the Fluor Corporation in Missouri state court alleging claims of breach of contract, tortious interference and veil piercing.

Represented Elan Corp., an Irish pharmaceutical company, in its successful defense of a hostile tender offer from Royalty Pharma.